跳至主要内容
临床试验/NCT01865721
NCT01865721已完成4 期

Optimizing the Use of Entonox® During Screening Colonoscopy: an Open Randomised Controlled Trial

Sheffield Teaching Hospitals NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Pain scores

研究概览

简要总结

This study will randomise patients undergoing screening colonoscopy to receive Entonox either continuously or as required.

Both these methods are used in the published studies of Entonox and in clinical practice.

Null hypothesis There will be no difference in pain levels between these two methods of Entonox administration

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having a bowel cancer screening programme colonoscopy

排除标准

  • Contraindications to Entonox
  • Previous bowel resections

研究组 & 干预措施

Continuous administration of Entonox

Active Comparator

Patients randomized to this arm will be asked to inhale Entonox throughout the insertion phase of colonoscopy

干预措施: Entonox (Drug)

As required administration of Entonox

Active Comparator

Patients randomised to this arm will be asked to use Entonox if and when they have pain

干预措施: Entonox (Drug)

结局指标

主要结局

Pain scores

时间窗: Day 1: Prior to discharge from endoscopy department

Patients will be asked about their overall recollection of pain on a 10 point numerical ratings scale prior to discharge

次要结局

  • Willingness to have a repeat colonoscopy(Day 1: Prior to discharge)
  • Pain scores(Day 1-4: Prior to discharge and 1-3 days later)
  • Use of analgesia and sedation(Day 1: During colonoscopy)
  • Patients satisfaction(Day 1-4: Prior to discharge and 1-3 days later)
  • Side Effects(Day 1: During colonoscopy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验